The average one-year price target for Medpace Holdings (NASDAQGS:MEDP) (BMV:MEDP) has been revised to $664.95 / share. This is an increase of 11.73% from the prior estimate of $595.15 dated October 20, 2026. These figures represent the aggregate consensus of anal
The average one-year price target for Medpace Holdings (NASDAQGS:MEDP) (BMV:MEDP) has been revised to $664.95 / share. This is an increase of 11.73% from the prior estimate of $595.15 dated October 20, 2026. These figures represent the aggregate consensus of anal
Democrats are up in Michigan, Texas, Kansas, Maine and Ohio, have an edge in Alaska and are effectively tied with Republicans in Iowa, new New York Times/Siena polls found.
The average one-year price target for Cadiz Inc. - Preferred Stock (NASDAQGM:CDZIP) has been revised to $45.17 / share. This is an increase of 10.05% from the prior estimate of $41.05 dated October 22, 2026. These figures represent aggregate analyst targets compi
The average one-year price target for Cadiz Inc. - Preferred Stock (NASDAQGM:CDZIP) has been revised to $45.17 / share. This is an increase of 10.05% from the prior estimate of $41.05 dated October 22, 2026. These figures represent aggregate analyst targets compi
Ukraine is becoming increasingly dependent on foreign aid as Russian air attacks further devastate its economy, according to a Bloomberg Economics report.
The average one-year price target for Bright Horizons Family Solutions (NYSE:BFAM) (XTRA:BHA) has been revised to $74.39 / share. This is a decrease of 15.23% from the prior estimate of $87.76 dated October 20, 2026. These figures represent aggregate analyst targets compiled by F
The average one-year price target for Bright Horizons Family Solutions (NYSE:BFAM) (XTRA:BHA) has been revised to $74.39 / share. This is a decrease of 15.23% from the prior estimate of $87.76 dated October 20, 2026. These figures represent aggregate analyst targets compiled by F
The average one-year price target for Strategy Inc - Preferred Stock (NASDAQGS:STRC) (DB:MIG2) has been revised to $196.39 / share. This is an increase of 15.43% from the prior estimate of $170.14 dated October 22, 2026.
The average one-year price target for Strategy Inc - Preferred Stock (NASDAQGS:STRC) (DB:MIG2) has been revised to $196.39 / share. This is an increase of 15.43% from the prior estimate of $170.14 dated October 22, 2026.
The average one-year price target for Zedge (NYSEAM:ZDGE) (DB:34Z) has been revised to $4.08 / share. This is a decrease of 33.33% from the prior estimate of $6.12 dated October 20, 2026. These figures represent aggregate analyst targets compiled from multiple sources and do not
The average one-year price target for Zedge (NYSEAM:ZDGE) (DB:34Z) has been revised to $4.08 / share. This is a decrease of 33.33% from the prior estimate of $6.12 dated October 20, 2026. These figures represent aggregate analyst targets compiled from multiple sources and do not
The average one-year price target for Glaukos (NYSE:GKOS) (DB:6GJ) has been revised to $247.31 / share. This is an increase of 22.10% from the prior estimate of $202.55 dated October 20, 2026. These figures represent aggregate analyst targets compiled from various sources and do
The average one-year price target for Glaukos (NYSE:GKOS) (DB:6GJ) has been revised to $247.31 / share. This is an increase of 22.10% from the prior estimate of $202.55 dated October 20, 2026. These figures represent aggregate analyst targets compiled from various sources and do
BAI Capital's Managing Partner Annabelle Yu Long told Bloomberg that the firm is nearing $700 million of an $800 million target as it attracts European LPs and Chinese strategic investors. (Source: Bloomberg)
The average one-year price target for Exponent (NASDAQGS:EXPO) (DB:EP5) has been revised to $85.82 / share. This is an increase of 11.42% from the prior estimate of $77.02 dated October 20, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not cons
The average one-year price target for Exponent (NASDAQGS:EXPO) (DB:EP5) has been revised to $85.82 / share. This is an increase of 11.42% from the prior estimate of $77.02 dated October 20, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not cons